IDH1 and astrocytoma (excluding glioblastoma): However, its ability to detect functional inactivation of CDKN2A/B through nonsynonymous CDKN2A/B mutation, which have recently been encountered in 2.6% of IDH-mut astrocytoma cases, or of heterozygous deletions might be reduced [15, 28].